The Relationship Between Quality Assurance Structure and Profitability in Iranian Pharmaceutical Industries
,
Abstract
Background: Quality Assurance Structure (QAS) plays an essential role in the profitability and market size of pharmaceutical companies. Accordingly, this study aimed to evaluate the quality certificates and QAS of pharmaceutical companies in Iran. Quality principles can increase consumer satisfaction, leading to elevated sales and profitability for companies. Besides, they have always been accompanied by growth and development. A well-established quality would be greatly valuable; if properly managed, it could influence the development of pharmaceutical companies.Methods: In this study, the data of sales, operating profit, quality certificates, organizational chart, and quality staff were received by companies. Moreover, we made appointments with each company and received the real data directly from the relevant officials. The quality certificates and relative percentage of quality staff were collected and compared with the domestic sales, exports, and operating profit of companies. Finally, the achieved results were analyzed to determine the relationship between financial and qualitative parameters.Results: The relationship between QAS and sales and corporate profitability was determined. The present study data indicated a relationship between the qualitative and financial sectors of pharmaceutical companies.Conclusion: Prior surveys and the obtained data suggested that quality structure and quality certificates significantly increase the domestic sale, export, and profitability of companies. However, numerous other parameters can also be involved in the sales volume of companies that require further investigations.
[1] Woodcock J. The concept of pharmaceutical quality. Am Pharm Rev. 2004; 7(6):10-5. https://www.researchgate.net/publication/279577343_The_concept_of_pharmaceutical_quality
[2] Gaynor M. Competition and quality in health care markets. Found Trends Microecon. 2007; 2(6):441-508. [DOI:10.1561/0700000024]
[3] Haleem RM, Salem MY, Fatahallah FA, Abdelfattah LE. Quality in the pharmaceutical industry-A literature review. Saudi Pharm J. 2015; 23(5):463-9. [DOI:10.1016/j.jsps.2013.11.004] [PMID] [PMCID]
[4] Kim JH, Scialli AR. Thalidomide: The tragedy of birth defects and the effective treatment of disease. Toxicol Sci. 2011; 122(1):1-6. [DOI:10.1093/toxsci/kfr088] [PMID]
[5] Rehman W, Arfons LM, Lazarus HM. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther Adv Hematol. 2011; 2(5):291-308. [DOI:10.1177/2040620711413165] [PMID] [PMCID]
[6] Rägo L, Santoso B. Drug regulation: History, present and future. In: van Boxtel CJ, Santoso B, Edwards IR, editors. Drug Benefits and Risks: International Textbook of Clinical Pharmacology. 2nd ed. Amsterdam: IOS Press; 2008. p. 65-77. https://books.google.com/books?id=idbvAgAAQBAJ&printsec=frontcover&dq
[7] Nally JD. Good manufacturing practices for pharmaceuticals. 6th ed. Boca Raton: CRC Press; 2016. [DOI:10.3109/9781420020939]
[8] Crowley R, FitzGerald LH. The impact of cGMP compliance on consumer confidence in dietary supplement products. Toxicology. 2006; 221(1):9-16. [DOI:10.1016/j.tox.2006.01.011] [PMID]
[9] Pandey P, Anju G. Quality management system in drug industry: A review. Biomed J Sci & Tech Res. 2018; 2(1):2177-9. [DOI:10.26717/BJSTR.2018.02.000653]
[10] Reddy GTK, Reddy GNK. Significance of pharmaceutical regulatory bodies-A review. Pharma Tutor. 2017; 5(8):15-22. https://www.pharmatutor.org/articles/significance-of-pharmaceutical-regulatorybodies-a-review
[11] Rust RT, Moorman C, Dickson PR. Getting return on quality: Revenue expansion, cost reduction, or both? J Mark. 2002; 66(4):7-24. [DOI:10.1509/jmkg.66.4.7.18515]
[12] Anderson M, Sohal AS. A study of the relationship between quality management practices and performance in
small businesses. Int J Qual Reliab Manag. 1999; 16(9):859-77. [DOI:10.1108/02656719910289168]
[13] Malerba F, Orsenigo L. The evolution of the pharmaceutical industry. Bus Hist. 2015; 57(5):664-87. [DOI:10.1080/00076791.2014.975119]
[14] Caruana A. Service loyalty: The effects of service quality and the mediating role of customer satisfaction. Eur J Mark. 2002; 36(7/8):811-28. [DOI:10.1108/03090560210430818]
[15] Kaura V, Durga Prasad CS, Sharma S. Service quality, service convenience, price and fairness, customer loyalty, and the mediating role of customer satisfaction. Int J Bank Mark. 2015; 33(4):404-22. [DOI:10.1108/IJBM-04-2014-0048]
[16] Manu M. Quality and customer satisfaction perspective in organisations by gap and total quality improvement methods [PhD dessertation]. Vaasa: University of Vaasa; 2011. https://www.semanticscholar.org/paper/Quality-and-customer-satisfaction-perspective-in-by-Manu/81d106f59c5e5903f0508336d7b169bf43db17c7
[17] Kai CLSCW, Khodabocus F. Quality Systems Implementation in the Pharmaceutical Industry. Univ Maurit Res J. 2009; 15(1):436-57. https://scholar.google.com/scholar?hl=fa&as_sdt=0%2C5&q=Quality+Systems+Implementation+in+the+Pharmaceutical+Industry.+&btnG=
[18] Murphy CN, Yates J. The International Organization for Standardization (ISO): Global governance through voluntary consensus: Abingdon, Oxfordshire: Taylor & Francis; 2009. https://books.google.de/ books?id=iXAeAQAAIAAJ&hl=de
[19] Cooper DE. Adequate controls for new drugs: Good manufacturing practice and the 1938 federal food, drug, and cosmetic act. Pharm Hist. 2002; 44(1):12-23. [PMID]
[20] Mojdehi S. Compare the model of Iran national quality award and the EFQM model. Chin Bus Rev. 2010; 9(9):61-4. https://scholar.google.com/scholar?hl=fa&as_sdt=0%2C5&q=+Compare+the+model+of+Iran+national+quality+award+and+the+EFQM+model.&btnG=
[21] Zamani M, Valmohammadi C. Evaluating the effects of the implementation of Iran National Quality Award new model (inqa) in Iranian organizations. Int J Qual Res. 2014; 8(3):311-22. http://ijqr.net/paper.php?id=306
[22] Organisation for Economic Co-operation and Development. Member countries [Internet]. 2021 [Updated 2021 July 10]. Available from: https://www.oecd.org/about/members-and-partners/
[2] Gaynor M. Competition and quality in health care markets. Found Trends Microecon. 2007; 2(6):441-508. [DOI:10.1561/0700000024]
[3] Haleem RM, Salem MY, Fatahallah FA, Abdelfattah LE. Quality in the pharmaceutical industry-A literature review. Saudi Pharm J. 2015; 23(5):463-9. [DOI:10.1016/j.jsps.2013.11.004] [PMID] [PMCID]
[4] Kim JH, Scialli AR. Thalidomide: The tragedy of birth defects and the effective treatment of disease. Toxicol Sci. 2011; 122(1):1-6. [DOI:10.1093/toxsci/kfr088] [PMID]
[5] Rehman W, Arfons LM, Lazarus HM. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther Adv Hematol. 2011; 2(5):291-308. [DOI:10.1177/2040620711413165] [PMID] [PMCID]
[6] Rägo L, Santoso B. Drug regulation: History, present and future. In: van Boxtel CJ, Santoso B, Edwards IR, editors. Drug Benefits and Risks: International Textbook of Clinical Pharmacology. 2nd ed. Amsterdam: IOS Press; 2008. p. 65-77. https://books.google.com/books?id=idbvAgAAQBAJ&printsec=frontcover&dq
[7] Nally JD. Good manufacturing practices for pharmaceuticals. 6th ed. Boca Raton: CRC Press; 2016. [DOI:10.3109/9781420020939]
[8] Crowley R, FitzGerald LH. The impact of cGMP compliance on consumer confidence in dietary supplement products. Toxicology. 2006; 221(1):9-16. [DOI:10.1016/j.tox.2006.01.011] [PMID]
[9] Pandey P, Anju G. Quality management system in drug industry: A review. Biomed J Sci & Tech Res. 2018; 2(1):2177-9. [DOI:10.26717/BJSTR.2018.02.000653]
[10] Reddy GTK, Reddy GNK. Significance of pharmaceutical regulatory bodies-A review. Pharma Tutor. 2017; 5(8):15-22. https://www.pharmatutor.org/articles/significance-of-pharmaceutical-regulatorybodies-a-review
[11] Rust RT, Moorman C, Dickson PR. Getting return on quality: Revenue expansion, cost reduction, or both? J Mark. 2002; 66(4):7-24. [DOI:10.1509/jmkg.66.4.7.18515]
[12] Anderson M, Sohal AS. A study of the relationship between quality management practices and performance in
small businesses. Int J Qual Reliab Manag. 1999; 16(9):859-77. [DOI:10.1108/02656719910289168]
[13] Malerba F, Orsenigo L. The evolution of the pharmaceutical industry. Bus Hist. 2015; 57(5):664-87. [DOI:10.1080/00076791.2014.975119]
[14] Caruana A. Service loyalty: The effects of service quality and the mediating role of customer satisfaction. Eur J Mark. 2002; 36(7/8):811-28. [DOI:10.1108/03090560210430818]
[15] Kaura V, Durga Prasad CS, Sharma S. Service quality, service convenience, price and fairness, customer loyalty, and the mediating role of customer satisfaction. Int J Bank Mark. 2015; 33(4):404-22. [DOI:10.1108/IJBM-04-2014-0048]
[16] Manu M. Quality and customer satisfaction perspective in organisations by gap and total quality improvement methods [PhD dessertation]. Vaasa: University of Vaasa; 2011. https://www.semanticscholar.org/paper/Quality-and-customer-satisfaction-perspective-in-by-Manu/81d106f59c5e5903f0508336d7b169bf43db17c7
[17] Kai CLSCW, Khodabocus F. Quality Systems Implementation in the Pharmaceutical Industry. Univ Maurit Res J. 2009; 15(1):436-57. https://scholar.google.com/scholar?hl=fa&as_sdt=0%2C5&q=Quality+Systems+Implementation+in+the+Pharmaceutical+Industry.+&btnG=
[18] Murphy CN, Yates J. The International Organization for Standardization (ISO): Global governance through voluntary consensus: Abingdon, Oxfordshire: Taylor & Francis; 2009. https://books.google.de/ books?id=iXAeAQAAIAAJ&hl=de
[19] Cooper DE. Adequate controls for new drugs: Good manufacturing practice and the 1938 federal food, drug, and cosmetic act. Pharm Hist. 2002; 44(1):12-23. [PMID]
[20] Mojdehi S. Compare the model of Iran national quality award and the EFQM model. Chin Bus Rev. 2010; 9(9):61-4. https://scholar.google.com/scholar?hl=fa&as_sdt=0%2C5&q=+Compare+the+model+of+Iran+national+quality+award+and+the+EFQM+model.&btnG=
[21] Zamani M, Valmohammadi C. Evaluating the effects of the implementation of Iran National Quality Award new model (inqa) in Iranian organizations. Int J Qual Res. 2014; 8(3):311-22. http://ijqr.net/paper.php?id=306
[22] Organisation for Economic Co-operation and Development. Member countries [Internet]. 2021 [Updated 2021 July 10]. Available from: https://www.oecd.org/about/members-and-partners/
| Files | ||
| Issue | Vol 7 No 1/2 (2021) | |
| Section | Original Article(s) | |
| Keywords | ||
| Sale Pharmaceutical industry Quality assurance Quality Pharmaceutical Drugs Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Kebriaeezade A, Khoramirad MS, Seyedifar M, Homayouni A. The Relationship Between Quality Assurance Structure and Profitability in Iranian Pharmaceutical Industries. JPPM. 2021;7(1/2):36-43.
